2007年度我院抗肿瘤药物应用情况分析

Analysis of Antineoplastic Drugs Used in our Hospital in 2007

目的:探讨我院2007年度抗肿瘤药物的应用情况。方法:统计我院2007年抗肿瘤药物使用的种类及所需费用,采用用药频度(DDDs)方法对抗肿瘤药用药频度和用药费用进行分析。结果:按照DDDs排序前3位分别为中药、抗肿瘤激素及其他类抗肿瘤药;按照销售金额排序前3位分别为抗肿瘤植物药、其他类抗肿瘤药及中药。抗肿瘤药物DDDs排序前3位的分别为来曲唑、平消胶囊、他莫昔芬,且其DDDs之和已达到抗肿瘤药物DDDs前10位的79.59%,来曲唑日均费用在10种药物中最低。结论:临床用药应根据患者病情选择价格低廉、疗效确切的药物,切忌以新药和植物药为主,以减轻患者和国家的经济负担。

Objective： To investigate the application of antineoplastie drugs in our hospital in 2007. Method： The data of frequency and cost of antineoplastic based on DDDs methods in 2007 were analyzed. Result： The top 3 antineoplastic drugs were traditional Chinese drugs, antineoplastie hormone and other antineoplastic drugs according to DDDs, and the top 3 antineoplastie drugs were plant amedica, other antineoplastic drugs and traditional Chinese drugs according to marketing amount of money. The top 3 antineoplastic drugs were pingxiao capsule, tamoxifen, and the sum was 79.59% in total sum of top 10 antineoplastic drugs according to DDDs. The cost of one day in letrozole was least in the top 10 antineoplastic drugs according to DDDs. Conclusion： The clinical application of antineoplastic drugs should be based on low prices and good effect. Guard against new drugs and medicinal plants -based drug in order to reduce financial burden.